Showing results (741-750 of 1,017) with videos related to

Sort By:
Pageof 102
Toxicology and Applied Pharmacology|May 1, 1994
Role of metallothionein in carcinogenesisM G Cherian, S B Howell, N Imura, et al.
Diabetologia|August 19, 2006
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study IIP J Talmud, J A Cooper, H Hattori, et al.
Molecular and Cellular Biology|January 1, 1994
A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinaseW Li, R Nishimura, A Kashishian, et al.
American Journal of Respiratory Cell and Molecular Biology|November 1, 1989
Human alveolar macrophages release a factor that inhibits phagocyte functionY Sibille, W W Merrill, G P Naegel, et al.
The EMBO Journal|June 14, 2003
Regulation of the Wnt signaling pathway by disabled-2 (Dab2)B A Hocevar, F Mou, J L Rennolds, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitroS Hall, G Chu, G Miller, et al.
Neuron|November 26, 1999
Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylationT Hiesberger, M Trommsdorff, B W Howell, et al.
The American Journal of Clinical Nutrition|November 10, 1998
Plant monoterpenes do not raise plasma high-density-lipoprotein concentrations in humansC J Cooke, M N Nanjee, P Dewey, et al.
Neuroscience|July 1, 1993
p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dendritesR S Fiore, V E Bayer, S L Pelech, et al.
Thrombosis and Haemostasis|April 1, 2000
Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasmaP K MacCallum, J A Cooper, J Martin, et al.
Pageof 102